Ramy A. Mahmoud - Dec 15, 2023 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Signature
/s/ Anthony Krick, Attorney-in-Fact
Stock symbol
OPTN
Transactions as of
Dec 15, 2023
Transactions value $
-$12,781
Form type
4
Date filed
12/20/2023, 12:21 PM
Previous filing
Sep 19, 2023
Next filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPTN Common Stock Award $0 +6.11K +1.19% $0.00 521K Dec 15, 2023 Direct F1
transaction OPTN Common Stock Sale -$12.8K -11.1K -2.13% $1.15 510K Dec 18, 2023 Direct F2
holding OPTN Common Stock 172K Dec 15, 2023 By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of performance-based restricted stock units (Performance RSUs) granted on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to receive one share of common stock of OptiNose, Inc.
F2 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units under multiple award agreements. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.